Top Abstract Purchase Related
Home
>
Node
>
Subnode

Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy

Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J.

Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122

2002

ISSN/ISBN: 1426-9686
PMID: 12420341
Document Number: 542564
Surgery is the basic treatment method of cholecystolithiasis. Traditional methods have been replaced laparoscopy. The aim of the study was the evaluation of haemostasis after classical and laparoscopic cholecystectomy. The studies were conducted in 48 patients suffering from chronic cholecystolithiasis--29 of them were operated on by laparoscopy, 19 patients were operated on by classical way. We revealed, that classical and laparoscopic cholecystectomy cause a similar increase of thrombin generating in vascular bed and are risk factors for occurrence of thrombo-embolic complications.

Document emailed within 1 workday
Secure & encrypted payments

Rość, D.; Zekanowska, E.; Kotschy, M.; Hryncewicz, W.; Jurkowska, M. 1994: Effect of vascular surgery on values of thrombin-antithrombin IIi complexes in patients with atherosclerosis of lower limb arteries Polski Tygodnik Lekarski 49(16-17): 360-362
Kienast, J.; Thompson, S.G.; Raskino, C.; Pelzer, H.; Fechtrup, C.; Ostermann, H.; van de Loo, J. 1993: Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis Thrombosis and Haemostasis 70(4): 550-553
Senent, M.; Bellart, J.; Zuazu-Jausoro, I.; Oliver, A.; Montserrat, I.; Ribera, L.; Tirado, I.; Cabero, L.; Fontcuberta, J. 1991: Markers of hypercoagulability during pregnancy: thrombin-antithrombin-IIi complexes and D dimer Sangre 36(1): 21-24
Rifón, J.; Collados, M.T.; Montes, R.; Chordá, C.; Páramo, J.A.; Rocha, E. 1992: Thrombin-antithrombin complexes and F1+2 prothrombin fragment in coronary revascularization surgery. Relationship with graft occlusion Sangre 37(4): 259-263
Giansante, C.; Fiotti, N.; Cattin, L.; Da Col, P.G.; Calabrese, S. 1994: Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors Thrombosis and Haemostasis 71(5): 581-586
Leroy-Matheron, C.; Gouault-Heilmann, M. 1994: Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements Thrombosis Research 74(4): 399-407
von Felten, A. 1992: Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex Therapeutische Umschau. Revue Therapeutique 49(12): 837-842
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
Nalçaci, M.; Pekçelen, Y. 1998: Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease Journal of International Medical Research 26(4): 206-208
Marciniak, E.; Gora-Maslak, G. 1984: The interaction of immobilized thrombin with human antithrombin IIi Thrombosis and Haemostasis 51(1): 27-31
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Fischer, A.M.; Tapon-Bretaudiere, J.; Bros, A.; Josso, F. 1981: Respective roles of antithrombin IIi and alpha 2 macroglobulin in thrombin inactivation Thrombosis and Haemostasis 45(1): 51-54
Tripodi, A.; Krachmalnicoff, A.; Mannucci, P.M. 1986: Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding Thrombosis and Haemostasis 56(3): 349-352
Innerfield, I.; Goldbloom, A.A.; Boyd, L.J. 1958: Plasma antithrombin elevations in buccal varidase-treated patients Surgery 43(6): 956-958
Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Boneu, B.; Sie, P.; Caranobe, C.; Cassigneul, J.; Pascal, J. 1982: Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis Thrombosis and Haemostasis 47(1): 78
Saxena, V.; Mishra, D.K.; Subramanya, H.; Satyanarayana, S.; Sharma, A. 2004: Antithrombin IIi assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases Indian Journal of Pathology and Microbiology 47(2): 210-212
Li, T.-H.; Chen, T.-H.; Lin, H.-S.; Liou, C.-W.; Liu, J.-S.; Chen, S.-S.; Chen, W.-H. 2008: Uncoupling of protein C and antithrombin IIi activity in cerebral ischemia patients associated with cutis marmorata Acta Neurologica Taiwanica 17(4): 233-238